Ownership history in HILLMAN CO · 19 quarters on record
This page tracks every 13F SEC filing in which HILLMAN CO reported a position in Nautilus Biotechnology Inc (NAUT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 200,000 | — | 0% | 0.14% | $390K | $1.95 |
| 2025 Q3 | UNCHANGED | 200,000 | — | 0% | 0.05% | $169K | $0.85 |
| 2025 Q2 | UNCHANGED | 200,000 | — | 0% | 0.06% | $145K | $0.73 |
| 2025 Q1 | UNCHANGED | 200,000 | — | 0% | 0.07% | $172K | $0.86 |
| 2024 Q4 | UNCHANGED | 200,000 | — | 0% | 0.14% | $336K | $1.68 |
| 2024 Q3 | UNCHANGED | 200,000 | — | 0% | 0.25% | $570K | $2.85 |
| 2024 Q2 | UNCHANGED | 200,000 | — | 0% | 0.22% | $468K | $2.34 |
| 2024 Q1 | UNCHANGED | 200,000 | — | 0% | 0.27% | $588K | $2.94 |
| 2023 Q4 | UNCHANGED | 200,000 | — | 0% | 0.28% | $598K | $2.99 |
| 2023 Q3 | UNCHANGED | 200,000 | — | 0% | 0.38% | $632K | $3.16 |
As of 2025 Q4 — sorted by position size